GlassScriptPhysician profile
Emily A Darr
NPI 1821295254
$5,463.68
in general payments reported to CMS, 2019-2025
30 companies · $2,012 in 2025
The $2,012 reported for 2025 was more than what 94% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $559 · 2020: $65.30 · 2021: $234 · 2022: $682 · 2023: $1,344 · 2024: $567 · 2025: $2,012.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,791 · Travel and Lodging: $1,132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,791.13 |
| Travel and Lodging | $1,131.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,018.97 | 2021-2025 | Intellis Adaptivestim, Accurian, Osteocool Rf Ablation System |
| Novus Surgical Consultants | $838.58 | 2024-2025 | |
| Bioventus LLC | $763.73 | 2022-2023 | Stimrouter Implantable Kit |
| Medtronic USA, INC. | $604.60 | 2019-2020 | |
| Ipsen Biopharmaceuticals, INC | $401.88 | 2022-2025 | Dysport |
| Arteriocyte Medical Systems, INC. | $378.32 | 2025 | Magellan |
| Curonix LLC | $205.74 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Inari Medical, INC. | $194.33 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Merz Pharmaceuticals, LLC | $92.39 | 2022-2023 | Xeomin |
| Depuy Synthes Sales INC. | $85.05 | 2023-2025 | Orthovisc, Monovisc |
| Zimmer Biomet Holdings, INC. | $70.59 | 2025 | Juggerknotless Soft Anchor |
| Abbvie INC. | $65.26 | 2022-2023 | Botox |
| Vertex Pharmaceuticals Incorporated | $64.24 | 2024-2025 | |
| Amgen INC. | $61.39 | 2024-2025 | Krystexxa |
| Fidia Pharma USA INC. | $56.86 | 2025 | Hymovis |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $56.17 | 2023-2024 | Wavewriter Alpha Prime 16 |
| Si-Bone, INC. | $55.27 | 2022-2024 | |
| Abbott Laboratories | $54.35 | 2021-2022 | |
| Treace Medical Concepts, INC. | $54.09 | 2024 | |
| Smith+Nephew, INC. | $48.79 | 2024-2025 | Stravix, Grafix Pl, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Organogenesis INC. | $45.50 | 2025 | Affinity |
| Spr Therapeutics, INC | $43.74 | 2025 | Sprint Pns System |
| Stryker Corporation | $36.85 | 2024 | Tornier Flex, Aequalis Ascend Flex, Aequalis Perform Reversed |
| Electronic Waveform Lab, INC. | $34.87 | 2023 | |
| Philips North America LLC | $32.16 | 2024 | (P84) Igt Devices Systems |
| Kuros Biosciences USA, INC | $27.92 | 2022-2023 | |
| Biotissue Holdings INC. | $22.41 | 2022 | |
| Eisai INC. | $19.47 | 2020 | |
| Innovation Technologies INC | $15.97 | 2025 | Irrisept |
| Spinal Simplicity, LLC | $14.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Darr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.